Clinical trials: Migraine Prophylaxis, active
Migraine Prophylaxis
Comparison of Propranolol, Flunarizine and Their Combination in Preventing Migraine in Adults in a Tertiary Care Hospital in Bangladesh
Migraine is a common and disabling neurological condition that affects quality of life, work productivity, and daily functioning.
- Trial name
- NCT07655700
- Testing
- Propranolol 80 mg, Flunarizine 10 mg, Propranolol 40 mg + Flunarizine 10mg
- Where
- Bangladesh
- Volunteers
- 177 people
- Sponsor
- Chittagong Medical College
Migraine Prophylaxis
Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine
A migraine is a moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and sound, or other symptoms.
- Trial name
- Kaleidoscope (NCT05707949)
- Testing
- Atogepant
- Where
- 86 sites in United States, Belgium and 14 more
- Volunteers
- 650 people
- Sponsor
- AbbVie
Migraine, Migraine Prophylaxis
The Real-world Study of Rimegepant Treatment in Female Migraine Patients of China
The goal of this observational study is to learn about the effects and safety of Rimegepant in women, especially young and middle-aged women, who take Rimegepant to treat their migraine in the real world.
- Trial name
- NCT06728345
- Testing
- Rimegepant
- Volunteers
- 300 people
- Sponsor
- The First Affiliated Hospital of Soochow University